New AI Imaging Detects ‘Striking’ Obesity-Related Neuropathy

A groundbreaking AI imaging technique has uncovered previously unseen nerve damage in people and mice linked to obesity, revealing a potential connection to GLP-1 drugs. This discovery could reshape our understanding of how obesity impacts the nervous system and highlights the importance of monitoring neuropathies in patients managing weight with these medications. The implications are significant, as it may lead to better preventive strategies and treatments for obesity-related health issues.